Locoregional Hyperthermia for Breast Cancer

Locoregional hyperthermia is a targeted treatment approach that uses controlled heat to raise the temperature of a specific area of the body containing cancerous tissue.

For selected patients with breast cancer—particularly locally recurrent or locally advanced disease—clinical research has evaluated locoregional hyperthermia in combination with radiation therapy. Several randomized studies and subsequent systematic reviews have reported improved local tumor response when hyperthermia is added to radiation in appropriately selected patients.

At Best Naturopathic Medicine in Santa Monica, locoregional hyperthermia is considered within an individualized integrative oncology approach. The goal is not to replace conventional cancer treatment, but to evaluate whether targeted hyperthermia may have a reasonable role as part of a patient's broader treatment plan.

For a broader explanation of the science, treatment approaches, and evidence surrounding cancer hyperthermia, see our cornerstone article:

Locoregional Hyperthermia for Cancer

What Is Locoregional Hyperthermia?

Hyperthermia therapy involves deliberately increasing the temperature of cancerous tissue or the surrounding treatment area.

Unlike whole-body heating approaches, locoregional hyperthermia focuses treatment on a defined region of the body.

The National Cancer Institute describes hyperthermia as a cancer treatment that may be used with other treatments such as radiation therapy and chemotherapy. Different technologies can be used to deliver heat, including external, regional, interstitial, and other specialized approaches.

For superficial or locally accessible tumors, external heating systems may be used to deliver controlled thermal energy to the treatment area.

The purpose is not simply to "heat the body." Rather, therapeutic hyperthermia attempts to achieve a controlled temperature within the target region while limiting unnecessary heating of surrounding normal tissue.

Why is heat being studied in cancer treatment?

Cancer cells can respond differently to elevated temperatures than normal tissues.

Hyperthermia may:

• Directly stress or damage cancer cells
• Alter tumor blood flow
• Increase cellular stress
• Affect proteins involved in cellular repair
• Potentially improve tumor oxygenation
• Increase the sensitivity of some cancer cells to radiation
• Potentially enhance the effects of certain anticancer treatments

The most clinically established rationale for breast cancer has been the potential for hyperthermia to enhance the effects of radiation therapy.

Considering Locoregional Hyperthermia for Breast Cancer?

Every breast cancer case is different. Whether you are exploring locoregional hyperthermia for a newly diagnosed cancer, locally advanced disease, or a recurrence, determining whether this approach is appropriate requires consideration of your diagnosis, treatment history, imaging, and current oncology treatment plan.

Schedule a consultation to discuss whether locoregional hyperthermia may be appropriate for your individual situation.

Schedule an Integrative Oncology Consultation

Located in Santa Monica, California, Best Naturopathic Medicine provides individualized integrative oncology consultations for patients exploring evidence-informed complementary approaches to cancer care.

What Does the Research Show for Breast Cancer?

The evidence for hyperthermia in breast cancer is not uniform across every stage or type of disease.

The strongest clinical evidence has historically involved locoregional recurrent breast cancer and locally advanced breast cancer, particularly when hyperthermia is combined with radiation therapy.

This distinction is important.

Locoregional hyperthermia should not be presented as a universally established treatment for every person diagnosed with breast cancer. Instead, the existing literature supports consideration of hyperthermia in particular clinical situations.

Hyperthermia and Radiation Therapy

Radiation therapy is an important local treatment for many breast cancer patients.

Researchers have investigated whether adding hyperthermia to radiation can improve the response of tumors within the treatment field.

One proposed mechanism is that heat may make cancer cells more susceptible to radiation-induced damage.

This is sometimes described as thermal radiosensitization.

The rationale is particularly relevant when a tumor is difficult to control with radiation alone or when local recurrence occurs.

Locoregional Recurrent Breast Cancer

One of the best-studied applications of hyperthermia is locoregionally recurrent breast cancer.

A recurrence may develop in the breast, chest wall, skin, or nearby tissues following previous treatment.

Management can be challenging, particularly when the patient has previously received radiation to the same region.

A systematic review and meta-analysis published in 2016 evaluated 34 studies involving more than 2,000 patients and found that, among two-arm studies, radiation plus hyperthermia produced a complete response rate of approximately 60%, compared with approximately 38% with radiation alone.

The analysis also included patients who had previously received radiation. Among those patients, reirradiation combined with hyperthermia produced substantial rates of complete response.

These findings are important, but they should be interpreted within the limitations of the underlying studies, including differences in treatment techniques, radiation doses, patient populations, and hyperthermia protocols.

Why might hyperthermia be particularly relevant for recurrence?

When breast cancer recurs locally, treatment options may be more limited than during initial treatment.

Some patients may have already undergone:

• Surgery
• Radiation therapy
• Chemotherapy
• Hormonal therapy
• HER2-directed therapy
• Other systemic treatments

In selected circumstances, local treatment may still be appropriate.

Hyperthermia has therefore been studied as a way of potentially improving local response when radiation is being used again.

Locally Advanced Breast Cancer

Hyperthermia has also been investigated in patients with locally advanced breast cancer.

One important study is the ESHO 1-85 randomized multicenter trial, conducted by the European Society for Hyperthermic Oncology.

The study included patients with locally advanced breast carcinoma and compared radiation therapy alone with radiation combined with weekly hyperthermia.

The investigators reported improved local tumor control with the addition of hyperthermia.

In the published analysis, the five-year local failure rate was 68% with radiation alone compared with 50% with radiation plus hyperthermia. Disease-free survival was also higher in the hyperthermia group.

The study is significant because it was randomized and multicenter, although the treatment protocol was developed decades ago and modern breast cancer management has evolved considerably since the study was conducted.

Therefore, the results provide evidence supporting the potential role of hyperthermia but should not be interpreted as proof that every modern breast cancer patient will benefit from the treatment.

Does the Temperature Matter?

An important aspect of hyperthermia research is that temperature alone does not tell the entire story.

Researchers also consider the duration of heating and the resulting thermal dose.

A systematic review of more than 2,300 breast cancer patients treated with radiation and hyperthermia found associations between thermal dose and treatment outcomes.

Higher thermal doses were associated with better clinical outcomes in several analyses, although higher temperatures can also increase the risk of thermal toxicity.

This highlights an important principle:

Effective hyperthermia requires controlled delivery of heat—not simply achieving the highest possible temperature.

The objective is to deliver an appropriate thermal treatment while maintaining patient comfort and minimizing injury to surrounding tissues.

How Might Locoregional Hyperthermia Complement Breast Cancer Treatment?

Hyperthermia is generally best understood as an adjunctive treatment, rather than a replacement for conventional oncology.

Depending on the clinical situation, breast cancer treatment may involve some combination of:

• Surgery
• Radiation therapy
• Chemotherapy
• Endocrine therapy
• HER2-directed therapy
• Immunotherapy
• Other targeted systemic treatments
• Supportive and integrative oncology care

The role of hyperthermia is to potentially provide an additional local treatment modality when the clinical circumstances make it appropriate.

The strongest evidence for breast cancer involves the combination of hyperthermia and radiation, particularly for locally recurrent or locally advanced disease.

Hyperthermia and Previously Irradiated Breast Cancer

One area of particular interest is the treatment of breast cancer recurrence in an area that has previously received radiation.

Reirradiation can present challenges because normal tissues have already been exposed to radiation.

Clinical studies have investigated whether adding hyperthermia to reirradiation can improve local tumor response.

In a large retrospective series of 248 patients with irresectable locoregional breast cancer recurrence, reirradiation combined with hyperthermia produced meaningful rates of local control.

This does not mean that reirradiation and hyperthermia are appropriate for everyone.

Patient selection is critical and should take into account:

• Location of recurrence
• Size and extent of disease
• Previous radiation dose and treatment field
• Time since previous radiation
• Skin and soft-tissue condition
• Overall health
• Other cancer treatments
• Goals of care

Decisions about reirradiation should be made collaboratively with an experienced radiation oncologist.

What Are the Potential Benefits of Hyperthermia for Breast Cancer?

Potential benefits depend on the individual patient's diagnosis and treatment plan.

Based on the available clinical literature, potential reasons for considering locoregional hyperthermia include:

1. Enhancing local treatment

Hyperthermia may increase the effectiveness of radiation within the treated region.

2. Improving local tumor response

Clinical studies in recurrent and locally advanced breast cancer have reported higher complete response rates when hyperthermia was combined with radiation.

3. Providing another option for selected recurrent disease

Hyperthermia has been investigated particularly in patients with locoregional recurrence, including some patients who have previously received radiation.

4. Supporting a multimodal treatment strategy

For appropriately selected patients, hyperthermia may be incorporated into a broader treatment plan that addresses both local disease and systemic cancer risk.

However, these potential benefits should not be interpreted as guarantees of tumor response, disease control, or survival.

What Are the Limitations of the Evidence?

Although the breast cancer hyperthermia literature is substantial compared with some other cancers, important limitations remain.

Studies have used different:

• Hyperthermia technologies
• Treatment temperatures
• Treatment durations
• Radiation protocols
• Patient populations
• Tumor characteristics
• Definitions of treatment response

Many of the strongest studies also involve recurrent or locally advanced disease rather than newly diagnosed early-stage breast cancer.

In addition, modern breast cancer treatment has changed substantially over the decades in which some of the foundational hyperthermia trials were conducted.

Therefore, evidence from historical hyperthermia studies should be interpreted in the context of contemporary oncology.

Most importantly, evidence for one hyperthermia technology or treatment protocol should not automatically be assumed to establish the effectiveness of another device or protocol.

Is Locoregional Hyperthermia a Replacement for Breast Cancer Treatment?

No.

Locoregional hyperthermia should not be presented as a replacement for surgery, radiation therapy, chemotherapy, endocrine therapy, HER2-directed treatment, immunotherapy, or other evidence-based cancer treatments when those treatments are medically indicated.

Instead, hyperthermia may be considered as an adjunctive or complementary treatment in selected clinical situations.

The appropriate approach depends on the patient's:

• Cancer stage
• Tumor biology
• Treatment history
• Current imaging
• Previous radiation exposure
• Overall health
• Treatment goals
• Conventional oncology recommendations

What Is the Role of Hyperthermia in Integrative Oncology?

Integrative oncology focuses on developing an individualized treatment strategy that combines appropriate conventional cancer care with evidence-informed complementary approaches.

Within this framework, locoregional hyperthermia represents a localized treatment modality rather than a general wellness therapy.

The central question is not simply:

"Can hyperthermia treat breast cancer?"

A more clinically useful question is:

"Is there a reasonable role for locoregional hyperthermia in this patient's specific cancer treatment plan?"

That distinction is important.

For one patient, hyperthermia may have little relevance.

For another patient with a difficult-to-treat local recurrence, previously irradiated tissue, or a locally advanced tumor, the available evidence may provide a stronger rationale for discussing the treatment with the oncology team.

Who Might Be Considered for Locoregional Hyperthermia?

Potential candidates may include selected patients with:

• Locally recurrent breast cancer
• Locally advanced breast cancer
• Chest-wall recurrence
• Superficial or otherwise technically accessible disease
• Disease being treated with radiation where hyperthermia is being considered as an adjunct

Eligibility cannot be determined from diagnosis alone.

A comprehensive evaluation should consider the patient's complete medical history, imaging, pathology, previous treatments, current treatment plan, and treatment goals.

Who May Not Be an Appropriate Candidate?

Hyperthermia is not appropriate for every patient.

Potential concerns may include:

• Tumors that cannot be adequately targeted
• Significant skin or soft-tissue injury
• Certain implanted medical devices or other treatment-specific considerations
• Inability to tolerate the treatment position
• Significant thermal sensitivity
• Clinical situations where the expected benefit does not justify the treatment burden

These considerations need to be evaluated individually.

What Does Locoregional Hyperthermia Treatment Feel Like?

The experience depends on the treatment technology and treatment area.

Patients may experience:

• Significant warmth
• Pressure from the treatment applicator
• Temporary discomfort
• Skin redness
• Local tenderness

Hyperthermia should be delivered with careful monitoring of the treatment area and attention to patient comfort.

The goal is controlled heating—not excessive or uncontrolled heat exposure.

Potential adverse effects can include burns, pain, and other localized thermal effects.

Locoregional Hyperthermia at Best Naturopathic Medicine

At Best Naturopathic Medicine in Santa Monica, locoregional hyperthermia is incorporated into an individualized integrative oncology approach.

The treatment is considered based on the patient's diagnosis, treatment history, current oncology plan, and goals of care.

Our approach is centered on careful evaluation rather than assuming that one treatment is appropriate for every patient.

When appropriate, we encourage communication and coordination with the patient's conventional oncology team.

Frequently Asked Questions

What is locoregional hyperthermia for breast cancer?

Locoregional hyperthermia is a treatment that uses controlled heat to raise the temperature of a specific region containing breast cancer. It has been studied most extensively as an adjunct to radiation therapy in locally recurrent and locally advanced breast cancer.

Does hyperthermia treat breast cancer?

Hyperthermia has demonstrated clinical activity in certain breast cancer settings, particularly when combined with radiation therapy. However, it should not be considered a standalone replacement for conventional breast cancer treatment.

Is hyperthermia effective for recurrent breast cancer?

Clinical research supports a potential role for hyperthermia combined with radiation in selected patients with locoregionally recurrent breast cancer. A systematic review and meta-analysis found higher complete response rates with radiation plus hyperthermia than with radiation alone.

Can hyperthermia be used after radiation therapy?

In selected patients with recurrent breast cancer, hyperthermia has been studied in combination with reirradiation. Previous radiation exposure is an important factor in determining whether reirradiation is appropriate.

Can hyperthermia be used with radiation therapy?

Yes. The combination of radiation and hyperthermia is one of the best-studied applications of cancer hyperthermia, including in breast cancer.

Does hyperthermia make radiation more effective?

One of the principal scientific rationales for combining hyperthermia with radiation is that heat can increase the sensitivity of cancer cells to radiation. Clinical studies in breast cancer have reported improved local response with the combination.

What temperature is used during hyperthermia?

Treatment temperatures vary according to the technology, tumor location, treatment protocol, and clinical objective. Research studies have used different temperatures and treatment durations, so there is no single temperature that applies to every patient.

Is hyperthermia FDA-approved for breast cancer?

Regulatory status depends on the specific hyperthermia technology and its intended use. Patients should discuss the specific device and treatment protocol with the treating clinician and determine whether it is being used within its applicable regulatory framework.

Is locoregional hyperthermia covered by insurance?

Coverage varies by insurance plan, treatment setting, technology, and clinical indication. Patients should verify coverage and financial responsibility before beginning treatment.

Can hyperthermia replace chemotherapy or radiation?

No. Hyperthermia should generally be considered an adjunctive treatment rather than a replacement for medically indicated conventional cancer treatment.

Is locoregional hyperthermia appropriate for every breast cancer patient?

No. The potential role of hyperthermia depends on the type, stage, location, and treatment history of the cancer, as well as the patient's overall health and treatment goals.

Explore Whether Locoregional Hyperthermia May Be Right for You

If you are considering locoregional hyperthermia as part of your breast cancer treatment plan, we can review your medical history and current treatment recommendations and discuss whether there may be a reasonable role for hyperthermia in your care.

Our approach is individualized and designed to complement—not replace—appropriate conventional oncology treatment.

Schedule a consultation to discuss whether locoregional hyperthermia may be appropriate for your individual situation.

Schedule an Integrative Oncology Consultation

Medical Disclaimer

The information on this page is provided for educational purposes and is not intended to diagnose, treat, cure, or prevent any disease.

Locoregional hyperthermia is not appropriate for every patient with breast cancer, and research findings from one cancer type, hyperthermia technology, or treatment protocol should not automatically be generalized to another.

Patients with breast cancer should discuss all treatment decisions with their qualified oncology team. Hyperthermia should not be used to replace medically indicated surgery, radiation therapy, systemic therapy, or other evidence-based cancer treatment.